Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Schematic description of the PLGA microsphere preparation process and... | Download Scientific Diagram
Hypothalamic Insulin-Sensitizing Effect of Exenatide in Dietary Induced Rat Model of Obesity | Bentham Science
GLP-1 receptor agonists in type 2 diabetes: An underused asset? Updated January 2021 - DiabetesontheNet
PDF] Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial | Semantic Scholar
Structures of native GLP-1, exenatide, and liraglutide. The N-terminal... | Download Scientific Diagram
A new mechanism of action of glucagon‐like peptide‐1 agonist in hepatic steatosis: Promotion of hepatic insulin clearance through induction of carcinoembryonic antigen‐related cell adhesion molecule 1 - Czech - 2018 - Hepatology
Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies - Metabolism - Clinical and Experimental
Mechanism of action of sitagliptin, vildagliptin, and exenatide. GLP-1... | Download Scientific Diagram
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | SpringerLink
Mechanism of the beneficial and protective effects of exenatide in diabetic rats in: Journal of Endocrinology Volume 220 Issue 3 (2014)
Exenatide – Beyond the Dish
Exenatide - Stepwards
Formation Mechanism, In vitro and In vivo Evaluation of Dimpled Exenatide Loaded PLGA Microparticles Prepared by Ultra-Fine Particle Processing System | SpringerLink
Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes - Clinical Therapeutics
Recent updates on GLP-1 agonists: Current advancements & challenges - ScienceDirect